Embolic stroke of undetermined source (ESUS) designates patients with nonlacunar cryptogenic ischemic strokes in whom embolism is the likely stroke mechanism. This session will discuss the latest advances in ESUS and highlight the related research priorities.
Renate Schnabel - Professor of Internal Medicine and Cardiology, interventional cardiologist and consultant in cardiology at University Heart and Vascular Center Hamburg, Germany
Hooman Kamel - Vice Chair for Research and Chief of Neurocritical Care in the Department of Neurology at Weill Cornell Medicine
George Ntaios - Associate Professor of Internal Medicine at the University of Thessaly, President Hellenic Stroke Organization
Diener Hans Christoph - Director of the Department of Neuroepidemiology at the Faculty of Medicine and Institute for Medical Informatics, Biometry and Epidemiology, Medical Faculty of the University Duisburg
Atrial cadiopathy and ESUS (Hooman Kamel)
Supracardiac atherosclerosis and ESUS (George Ntaios)
Short runs of atrial fibrillation and ischemic stroke (Renate Schnabel)
Date and time:
4 PM CEST on 24th November, 2021
Achieving our vision of a life free from stroke is a task that WSO cannot achieve alone. We are committed to building our partnerships at the global, regional and national level to scale up and deliver improvements in prevention, treatment and support to reduce the burden of stroke.